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Abstract: The present investigation was undertaken to study the effect of Hibiscus rosa sinensis leaf extract fractions
on islets of Langerhans, total antioxidant activity in non-obese diabetic (NOD) mouse. Two sets of experiments
were conducted. First experiment was designed to test the hypoglycemic properties of different isolated fractions.
Five fractions were screened for hypoglycemic property. Fractions F3, F4 and F5 showed hypoglycemic in NOD mice.
Second set of experiment was conducted to assess the effects of above fractions on the diameter of islets of
Langerhans and on the β-cells number and total antioxidant capacity (TAC). All the fractions had a significant effect
in the enhancement of diameter of islets of Langerhans and the β-cell number and antioxidant active (total antioxidant
capacity) compared with control NOD mice.
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INTRODUCTION
Diabetes mellitus describes a heterogeneous group of
metabolic disorders characterized clinically and
metabolically by elevated blood glucose levels
(hyperglycemia). These features result from the low effect
of insulin, either because of insulin deficiency alone
(type-1diabetes mellitus: type-1D), or because of
defective insulin secretion in relation to a decrease in
insulin sensitivity (type-2 diabetes mellitus) (Ganong,
1999).
Type-I diabetes or insulin-dependent diabetes mellitus
(IDDM) is thought to be an autoimmune disease in
humans (Castano and Eisenbarth, 1990; Rossini et al.,
1989; Acha-Orbea and McDevitt, 1990). Nonobese
diabetic (NOD) mice spontaneously develop diabetes,
which has features similar to those of human type-1
diabetes, a polygenetic disease resulting from an
inadequate amount of β-cells mass caused by T-cell–
mediated autoimmune destruction of β-cells (Makino et
al., 1980; Cahill and McDevitt, 1981; Gorsuch et al., 1981).
Hibiscus rosa sinensis L. (Malvaceae) is a popular herb
in traditional system of medicine. Ethanomedical
information states that the plant possesses powerful
antioxidant (Masaki et al., 1995), antidiabetic (Sachdewa
and Khemani, 2003) cardioprotective (Gauthaman et al.,
2006), hepatoprotective (Obi and Uneh, 2003), and
anticancer (Sharma et al., 2004) properties in various
models.
The islets of Langerhans play a central role in the
hormonal control of fuel metabolism and particularly of
glucose homeostasis. Maintenance of a normal plasma
glucose concentration during periods of food
consumption and fasting requires a delicate balance
between glucose production and utilization. Although
control of glucose homeostatsis implicates many
hormonal, neural, and autoregulatory factors, insulin and
glucagon, two secretory products of the islets, are the
major determinants of this control. Insulin is secreted by
the β-cells of the islets in response to nutrients to
promote energy storage in target organs (liver, muscle,
and adipose tissue); glucagon release by the α-cell is
then inhibited in the postabsorptive state, while insulin
secretion falls, glucagon is stimulated and activates
glycogenolysis and gluconeogenesis; this reciprocal
change in the plasma insulin-glucagon concentration
ratio will favor energy store consumption. Biosynthesis
and secretion of these two hormones must be tightly
regulated to match fuel production and delivery to
metabolic demands. (Philippe, 1991). Various studies have
shown that diabetes mellitus is associated with increased
formation of free radicals and decrease in antioxidant
potential. Due to these events, the balance normally
present in cells between radical formation and protection
against them is disturbed. This leads to oxidative damage
of cell components such as proteins, lipids, and nucleic
acids. In both insulin dependent (type- 1) and non-
insulin-dependent diabetes (type- 2) there is increased
oxidative stress (Nazirog¡lu and Butterworth, 2005).
Nutritional factors including antioxidants have great
influence in the management of diabetes mellitus and its
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complications (Alberti et al., 1997; Packer et al., 2000).
An imbalance between oxidative stress and antioxidative
defense mechanisms in diabetics can result in cell and
tissue damage and accelerate diabetic complications.
Administration of appropriate antioxidants could prevent
or retard diabetic complications to some extent (Packer
et al., 2000). Recently, some evidences suggest that
oxidative stress may play an important role in the etiology
of diabetes and diabetic complications (Shinn, 1998). In
healthy individuals, oxidative damage to tissue is
prevented by a system of defenses which includes
antioxidant enzymes and small molecules with
scavenging ability such as antioxidant vitamins (Polidori
et al., 2000) However, relationships between the
antioxidant status, glycemic control, and the risk for
development of chronic complication in individuals with
diabetes are not completely clear (Abuaisha et al., 1998).
Antioxidants play an important role to protect against
damage by reactive oxygen species and their role in
diabetes has been evaluated. Many plant extract and
products were shown to possess significant antioxidant
activity. The present investigation was undertaken to
study the effect of Hibiscus rosa sinensis leaf extract
fractions on islets of Langerhans, total antioxidant
activity in non-obese diabetic (NOD) mouse.
MATERIALS AND METHODS
Animals models: NOD mice were originally obtained from
Center for Cellular and Molecular Biology (CCMB, CSIR),
Hyderabad and maintained under standard environmental
conditions of 12:12 h L: D cycle. Mice were fed with
standard diet supplied by Ambruth Feeds Pvt Ltd
Bangalore and water ad libitum. Healthy adult of (30
weeks old) NOD mice of either sex weighing 25-30 g were
selected for the study from the Central Animal Facility of
the department. All the selected animals showed the
fasting blood glucose values of e” 242 mg/100 ml indicting
hyperglycemia, the diabetic status. Experimental
protocols were approved from Institutional Animal Ethics
Committee (IAEC).
Extraction and fractionation: Healthy disease free leaves
of H. rosa sinensis were collected from the garden of our
University campus. The authenticity of the plant was
confirmed by a taxonomist of the Department of Botany.
University of Mysore, Mysore, and preserved in the form
of herbarium. Collected leaves were shade dried and
ground in warring blender. The ground powder was
extracted in soxhlet apparatus using ethanol until the
final drop of the extract became color less. The extract
was dried using evaporator.Details of extraction and
fractionation of H. rosa sinensis is published elsewhere
(Moqbel et al., 2011). After fractionation the five fractions
were obtained namely ethyl acetate soluble fraction (F1),
ethyl acetate insoluble fraction (F2), chloroform fraction
(F3), the basic fraction (F4) and neutral fraction (F5).
First experiment was conducted to test the hypoglycemic
properties of the five fractions obtained. Since F2 did not
dissolve in tween-80, 1%, remaining fractions F1, F3, F4
and F5 were dissolved in tween-80 (1%) with two
concentrations of 100 and 200 mg/kg body weight and
fed orally to NOD mice. The animals with body weight
ranging between 25-30 g they were allowed with free
access to standard laboratory food and water ad libitum
throughout the experiment. NOD mice were randomly
divided in to the following groups with five animals in
each.
Group  I: NOD diabetic control treated with vehicle alone.
Group II: NOD mice treated with insulin (1 ml of Biphasic
isophane insulin purchased from pharmaceutical
company dissolved in 100 ml saline and 0.1 ml/mouse /
day was injected (intra peritoneal). Group III: NOD mice
treated with 100 mg/kg body weight of F1.Group  IV: NOD
mice treated with 200 mg/kg body weight of F1.Group V:
NOD mice treated with 100 mg/kg body weight of F3.
Group VI: NOD mice treated with 200 mg/kg body weight
of F3.Group VII: NOD mice treated with 100 mg/kg body
weight of F4.Group VIII: NOD mice treated with 200 mg/
kg body weight of F4.Group IX: NOD mice treated with
100 mg/kg body weight of F5.Group X: NOD mice treated
with 200 mg/kg body weight of F5.
Since F1 did not show hypoglycemia whereas fractions
F3, F4 and F5 showed hypoglycemia. Hence second
experiment was conducted choosing F3, F4 and F5 fractions
for detailed investigation to study antioxidant activity
and the effect on the Islets of Langerhans.
Experimental protocols: NOD mice were randomly
divided into following 8 groups of 5 animals in each group:
Group- I: NOD diabetic control treated with vehicle alone,
Group- II: NOD mice treated with insulin (1 ml of Biphasic
isophane insulin purchased from pharmaceutical
company dissolved in 100 ml saline and 0.1 ml/mouse /
day was injected intraperitoneally).
Group- III: NOD mice treated with 100 mg / kg b.w of F3
Group- IV: NOD mice treated with 200 mg/Kg b.w of F3
Group- V: NOD mice treated with 100 mg / kg b.w of F4
Group- VI: NOD mice treated with 200 mg/Kg b.w of F4
Group- VII: NOD mice treated with 100 mg / kg b.w of F5
Group- VIII: NOD mice treated with 200 mg/Kg b.w of F5
F3, F4 and F5 were dissolved in tween- 80 (1%) and Fed
orally to the animals of group- III - VIII. The experiment
was conducted for four weeks.
In the above experiment, body weight was recorded at
the commencemen of the experiment (0 day) and weekly
to the day of autopsy. Final body weight and pancreas
weight was also recorded and later pancreas weight was
converted into relative weight (weight (mg) / 100 g b.w).
Overnight fasted animals were used in all the experiments.
During the tenure of the experiment, blood was drawn
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from tail of conscious mice once in a week in every group
to estimate glucose level by glucometer.
Morphometric analysis: All the groups had 5 NOD mice
each in it.  From single mice 100 islets were measured
from 100 randomly selected cross sections of the pancreas
from each mice and also their β-cells were counted, totally
500 islets were considered for the morphometric analyses
from each group. Islets of Langerhans measurement was
done at their longest axis at 400 X and size was calculated
and it was done using ocular microscope fixed in Correct
Seiwa Optical (No. 621734) light microscope (diameter-at
horizontal and vertical axis of every islet was measured
and divided by 2). The total number of β-cells of the
islets was done by point counting using blood cell counter
(Chandavar and Naik, 2004).
CHP stained histological sections slides were
photographed using Olympus B × 60 Microscope.
Total antioxidant capacity was estimated based on the
method of Berker et al., (2009). Briefly 0.1 ml of sample,
0.9 ml of  EtOH (96%), 5 ml H2O, 1.5 ml of 1 M HCl, 1.5 ml
of ferricyanide solution (1%), 0.5 ml of 1% sodium dodecyl
sulfate (SDS), and 0.5 of FeCl3.6H2O (0.2%) were added
and the volume was made up to 10 ml. the mixture was
incubated at 50o C on a water bath for 20 min cooled and
optical density (OD) was absorbed at 750 nm (A750). The
total antioxidant activity was calculated by using the
formula:  TAC (mmol TR/g) = (Af/εTR)×(Vf/Vs)×r (Vcup/
m).
Statistical analysis: The mean value of each parameter
was computed considering data on five NOD mice in
each group. The mean values of each parameter of
different groups were compared using one-way analysis
of variance (ANOVA) followed Duncan’s new multiple
range test fixing a minimum significance level of p < 0.05.
RESULTS
Table 1 shows the result of first experiment on effect of
different fractions obtained on the serum glucose level
of all the groups. Group-I animals (NOD diabetic control)
exhibited hyperglycemia throughout the experiment
indicating diabetic status where as group-II animals after
treatment with insulin significantly reduced the serum
glucose level to non diabetic status. Group-III animals
(F1 with 100 mg/kg body weight) continued to maintain
diabetic status where as group IV animals (F1 with 200
mg/kg body weight) showed significant reduction in serum
glucose level but failed to attain non diabetic status.
Animals treated with F3 and F5 with different
concentrations (group-V and group-VI, Group-IX and
group-X) exhibited the serum glucose level even lesser
than insulin treated group (group-II). Animals of group-
VII and-VIII treated with fraction F4 showed a significant
reduction of serum glucose level compared to NOD
diabetic control; however F4 with 200 mg/kg body weight
performed better.
Table 2 shows the mean values of weight of pancreas,
relative weight of pancreas, islet diameter and β-cells
number per islet. Absolute weight and relative weight of
pancreas did not differ significantly in all the experimental
groups, however there were significant enhancement in
the diameter of the islets in the experimental groups
compared to NOD mice (group-I). β-cells number were
maximum in the islets after oral feeding of F3 with 100 mg/
kg body weight (group-III). There was a significant
enhancement in the number of β cells in all the remaining
groups compared to NOD mice (group-I).
Fig. 1 shows total antioxidant capacity (TAC) in different
groups of experimental animals. TAC value was found to
be 0.029±0.0004 mmol/g in NOD mice, where as the value
ranged from 0.041± 0.0004 to 0.061± 0.0005 in different
experimental groups with fractions F3, F4, F5 and insulin.
TAC of group V reached almost with that of insulin treated
group.
DISCUSSION
It is evident from Table-1 that fraction F1 had no effect in
lowering the blood serum glucose level in NOD mice
where as the fraction F3, F4, F5 had reduced the serum
glucose level significantly to non diabetic status.
Comparatively fraction F3 performed better in lowering
blood serum glucose level than fractions F4 and F5. The
fraction F5 performed better than fraction- 4. Fraction- 4
with 200 mg/kg body weight reduced the blood serum
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Fig. 1. Effect of of  leaf extract of H.  rosa sinensis (HLE)
fractions (F3, F4, F5) on Total antioxidant (mmol/g) of
experimental groups.
The vertical bars are showing mean values of total antioxidant
(mmol/g). Lines above the bars indicate standard error (SE).
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Group 0 day 7th day 14th day 21st day 28th day 
I. NOD mice control 287±2.77a 279.8±2.82a 280±3.65a 283±3.66a 281.6±3.79a 
II. Insulin injected NOD mice 242.4±1.38b 202.95±4.09b,g 182.50±1.14b 131.75±1.59b,e 103.37±2.13b 
III. HLE.F1 100 mg/kg b.w 410.6±3.72c 365.7±4.69c 370.3±6.13c 314±16.68a 326.8±7.74c 
IV. HLE.F1 200 mg/kg b.w 280.8±3.2
a 211.6±3.50b 275.4±12.87a 213.4±6.14c 213.2±5.15d 
V.  HLE.F3 100 mg/kg b.w 290.4±2.84a 104.4±3.67d 93.2±2.63d 95.8±1.24d 94.4±1.86e,g 
VI.  HLE. F3 200 mg/kg b.w 278.6±4.89a 126.1±4.29e 161.4±3.59e 120.6±3.08b 90.2±25g 
VII.  HLE.F4100 mg/kg b.w  258.22±3.77d 184.67±4.75f 170.14±6.51b,e 144.48±8.71e 119.02±1.68f 
VIII. HLE.F4 200 mg/kg b.w 264.48±4.12d 196.4±7.39f,g 143.54±4.51f 122.94±3.27b,e 108.58±3.27b,f 
IX. HLE. F5 100 mg/kg b.w 280.8±3.57a 204±5.74b,g 165.2±2.37e 118.8±2.92b 92.1±2.63e,g 
X. HLE. F5 200 mg/kg b.w 326.6±7.77e 184.8±4.84f 129.2±3.06f 113±3.4b,d 83.8±3.15g 
ANOVA F Value (df=9,40) 130.705 240.725 221.762 115.651 553.615 
Table 1. Effect of leaf extract of  H.  rosa sinensis (HLE) all fractions (F1,F3, F4, F5) on serum glucose level (mg/dl).
Values are mean ± SE from 5 animals in each group. All values are significant at P<0.05 vs diabetic control (Gr.1)
Groups Weight of pancreas Relative weight of  
Pancreas 
Diameter of islet  
in µm 
Number of β cell/islet 
I. NOD diabetic control 0.185 ±0.004a 0.682 ±0.011a,b 121.52 ±2.43a 93.1 ±2.69a 
II. Insulin injected NOD Mice 0.194 ±0.009a 0.611 ±0.028a 154.02 ±3.32b 143.36 ±1.57b 
III. HLE.F3-100 mg/kg/b.w 0.201 ±0.001a,b,c 0.625 ±0.006a 145.66 ±2.19c,e 170.37 ±1.47c 
IV. HLE.F3. 200 mg/kg b.w 0.206 ±0.009a,b,c 0.635 ±0.029a 140.04 ±2.67c,d 146.4 ±7.48b 
V. HLE.F4-100 mg/kg/b.w 0.224 ±0.009
b 0.724 ±0.029b 137.6 ±1.87d 129.24 ±2.90d 
VI. HLE.F4-200 mg/kg/b.w 0.197 ±0.003a,c 0.635 ±0.014a 138.8 ±1.69d 130.2 ±0.54d 
VII. HLE.F5-100 mg/kg/b.w 0.206 ±0.003a,b,c 0.640 ±0.008a 149.2 ±0.98b,e 138.2 ±1.42b,d 
VIII. HLE.F5-200 mg/kg/b.w 0.218 ±0.010b,c 0.68 ±0.038a,b 150.4 ±1.49b,e 143.4 ±2.01b 
ANOVA F Value (df=7,32) 3.113 2.583 21.746 45.972 
Table 2. Effect of leaf extract of H. rosa sinensis (HLE) fractions (F3, F4, F5) treatment on pancreas, Islet size and β- cell number.
The values are given as means ± SE; df, degrees of freedom in each group. Means with different superscripts (a, b and c) within a
column are significantly different from each other at p<0.05 as determined by Duncan’s multiple range test.
glucose level to non diabetic status. Treatment of H.rosa
sinensis leaf extract in different fractions (F3, F4, F5) to
the NOD mice had significantly increased the islet size
and β-cell number when compared to the diabetic group
(group-I). The diminished islet size and β-cells numbers
resulted in the histopathology of diabetic pancreas.
Reduction of β-cells number and islet diameter indicates
the loss of integrity between the cells in the islet.
Decreased activity of the antioxidant enzymes and
depletion of total antioxidant capacity may increase the
susceptibility of diabetic patients to oxidative injury. The
recent report shows that the number of adult β-cells can
increase through self duplication/proliferation (Dor et al.,
2004) supports present study that increase in the islet
size and β-cells number in the diabetic islets can happen
after treatment with H.rosa sinensis leaf extract in different
fractions (F3, F4, F5). Because of oral treatment of different
fractions (F3, F4, F5) to NOD mice there was not only
enhancement of diameter of islets and increase in the
number of β-cells in the islet but also in the secretion of
insulin (Moqbel et al., 2011) for fractions F3 and F5. F4
also enhanced insulin secretion (unpublished data)
compared to NOD mice. Thus these fractions may contain
the active component/s that enhance insulin secretion
in NOD mice by one or several the mechanisms.
Enhancement of insulin secretion in NOD mice may be
through antioxidant supplies which may help to prevent
clinical complications of diabetes mellitus (Rahbani-
Nobar et al., 1999). However, relationships between the
antioxidant status, glycemic control and the risk for
development of chronic complications in individuals with
diabetes are not completely understood (Abuaisha et
al., 1998).
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